NOD2 and Crohn disease: For example, the NOD2-specific agonist muramyl dipeptide promoted TNF-α secretion from MCs and, in vivo, a significant increase in NOD2 positive MCs was reported in colonic mucosal biopsies from Crohn ́s disease patients compared to those coming from ulcerative colitis or control biopsies (195).